Skip to main content

Passion Flower

Scientific Name(s): Passiflora incarnata L.
Common Name(s): Apricot vine, Corona de cristo, Fleischfarbige, Fleur de la passion, Flor de passion, Granadilla (species with edible fruit), Herba passiflorae, Jamaican honeysuckle (Passiflora laurifolia), Madre selva, Maracuja (Brazil), Maracuva (Peru), Maypop, Passion flower, Passion fruit, Passion vine, Passionflower, Passionsblumenkraut, Purple passion flower, Water lemon (P. laurifolia), Wild passion flower

Medically reviewed by Last updated on Mar 7, 2024.

Clinical Overview


Passion flower has been examined for use in treating anxiety, insomnia, diabetes, menopausal symptoms, and cough. However, there are limited quality clinical trials to recommend passion flower for any indication.


There are limited quality clinical data to support therapeutic dosing guidance.


Contraindicated during pregnancy. Use should generally be avoided in patients with cardiac arrhythmias and abnormalities.


Passion flower is a known uterine stimulant; avoid use in pregnancy. Information is lacking regarding use during lactation.


Caution is warranted with concomitant consumption of CNS-active medicines and coadministration of drugs that prolong the QT interval.

Adverse Reactions

Nausea, vomiting, dizziness, and drowsiness have been reported with passion flower consumption, as well as prolongation of the QT interval and episodes of ventricular tachycardia. Hypersensitivity, occupational asthma, and rhinitis have also occurred.


Information is limited and cannot be extrapolated from one species to another. Passion flower has "generally recognized as safe" (GRAS) status according to the US Food and Drug Administration (FDA). Certain Passiflora species are reported to exhibit genotoxicity and to contain cyanogenic constituents, and are also associated with hepatobiliary and pancreatic toxicity.

Scientific Family


The term "passion flower" refers to many of the approximately 400 species of the genus Passiflora, which primarily grow as vines. Some species are noted for their ornate flowers, others for their edible fruit. Common species include P. incarnata, P. edulis, P. alata, P. laurifolia, and P. quadrangularis. Those with edible fruit include P. incarnata, P. edulis, and P. quadrangularis, the latter being one of the major species grown commercially for its fruit. Passiflora species are native to tropical and subtropical areas of the Americas. In the United States, P. incarnata is found from Virginia to Florida and as far west as Missouri and Texas. It is a woody, evergreen climber and grows rapidly, reaching up to 6 m in height.Mirrodi 2013, Modabbernia 2013 The flowers of Passiflora have 5 petals, sepals, and stamens; 3 stigmas; and a crown of filaments. The ovoid fruit is 4 to 5 cm long, has a pulpy consistency, and includes many small seeds.Khan 2009, USDA 2018, WHO 2007


The "passion flower" was discovered in 1569 by Spanish explorers in Peru who saw the flowers as symbolic of the passion of Christ and as a sign of Christ's approval of their efforts, which became the origin of the scientific and common names. The folklore surrounding this plant possibly dates to even earlier than the 16th century. The floral parts are thought to represent the elements of the crucifixion (3 styles represent 3 nails; 5 stamens for the 5 wounds; the ovary resembles a hammer; the corona as the crown of thorns; the petals represent the 10 true apostles; the white and bluish-purple colors those of purity and heaven). In Europe, passion flower has been used in homeopathic medicine to treat pain, insomnia related to neurasthenia or hysteria, and nervous exhaustion. It has also been used for bronchial disorders (particularly asthma), inflammation, inflamed hemorrhoids, climacteric complaints, pediatric attention disorders, pediatric nervousness and excitability, and as a compress for burns.Khan 2009, USDA 2018, WHO 2007


The official passion flower is considered to be P. incarnata, which is used for the herbal supplement form. Variations in constituents among species exist.

Key constituents in P. incarnata include flavonoids, maltol, cyanogenic glycosides, and harman indole alkaloids. The indole alkaloids isolated from P. incarnata (ie, harmol, harmine, harmalol, harmaline) consist of a benzene ring that is fused to a 5-membered heterocycle with 1 nitrogen atom, which closely resembles benzodiazepines.Hamid 2017 Flavonoid content (2.5%) includes flavone di-C-glycosides, schaftoside, isoschaftoside, isovitexin, iso-orientin, swertisin, vicenin, lucenin, saponarin, and passiflorine. Free flavonoids include apigenin, luteolin, quercetin, and kamferol. Additionally, coumarins have been identified in the root of the plant, and lycopene is present in large amounts in the aerial parts. Flavonoid determination by high-performance liquid chromatography, mass spectral analysis, and other methods has been extensively reported.Devi Ramaiya 2013, Dhawan 2004, Khan 2009, WHO 2007, Wohlmuth 2010

Uses and Pharmacology

Anti-inflammatory activity

Animal data

Anti-inflammatory actions of passion flower, including decreases in inflammation, leukocyte migration, and granuloma mass, have been demonstrated in animal models.(Sasikala 2011, WHO 2007) A study in rats indicated a potential benefit in treatment of neuropathic pain through opioidergic effects of P. incarnata.(Aman 2016)

Clinical data

In a clinical study of purple passion fruit peel extract, a reduction in pain and stiffness was shown in adults with osteoarthritis of the knee.(Farid 2010)

Antimicrobial activity

In vitro data

Antimicrobial activity has also been demonstrated in vitro against Trichomonas vaginalis and Helicobacter pylori, as well as other fungal and bacterial organisms.(Lam 2009, Masadeh 2014, Rocha 2012, WHO 2007)

Antioxidant activity

Animal and in vitro data

Antioxidant effects have been reported for certain Passiflora species.(Lourith 2013, Masteikova 2008, Sathish 2011)

Antitussive effects

Animal and in vitro data

In mice with sulfur dioxide–induced cough, a methanolic extract of P. incarnata leaves was associated with 39.4% and 65% cough inhibition at oral doses of 100 and 200 mg/kg, respectively. Effects were comparable to those with oral codeine phosphate 10 and 20 mg/kg, respectively.(Dhawan 2002)

Clinical data

P. edulis has been clinically evaluated for its effects on coughing. In a randomized, double-blind, placebo-controlled study, purple passion fruit peel extract (P. edulis) 150 mg/day orally for 4 weeks significantly reduced coughing, wheezing, and shortness of breath in patients with asthma (P<0.05).(Watson 2008)

Cardiovascular effects

Animal and in vitro data

Increased contractility in isolated guinea pig hearts has been demonstrated,(WHO 2007) while the presence of a vasorelaxing agent in passion fruit seeds (P. edulis) has been identified.(Sano 2011) Antihypertensive activity in rats has been described for passion fruit peel extract and the fruit pulp.(Konta 2014, Lewis 2013) Compounds identified from P. edulis extracts have exhibited anticoagulant activity in vitro.(Sato 2012)

CNS/Anxiolytic effects

The CNS effects of P. incarnata are believed to occur through modulation of the gamma-aminobutyric acid (GABA) system.(Appel 2011, Baek 2014) Passionflower extract exerts partial agonistic activity at the benzodiazepine receptor.(Baek 2014)

Animal and in vitro data

Multiple animal studies exist demonstrating the effects of Passiflora on the CNS, including stimulant and depressant activity.(Deng 2010, Sarris 2013) Studies evaluating activity against nicotine sensitization(Breivogel 2012) and use in the setting of alcohol dependency and withdrawal in rats have suggested benefit.(Schnuck 2017, Tomczyk 2012) In a study of mice, passionflower extract given for 7 weeks resulted in a reduction in anxiety and improvement in memory.(Jawna-Zboinska 2016) The methanolic extract of the aerial part of P. incarnata was associated with anxiolytic effects; however, the roots were devoid of this activity.(Dhawan 2001) When compared to P. edulis, the methanolic extract of P. incarnata 125 mg/kg was associated with anxiolytic activity while the P. edulis extract exerted minimal anxiolytic activity.(Dhawan 2001) Another study found the chloroform and butanol fractions of a hydroethanol extract from P. incarnata was associated with anxiolytic effects; however, the petroleum ether fraction did not exert any effects.(Sampath 2011)

In one study, P. incarnata extract exerted antiparkinsonian effects and enhanced cognitive activity in mice.(Ingale 2017) In another study, 5 different extracts of P. incarnata were studied, and 2 were found to exert antiepileptic activity in an animal model of PTX-induced seizures. All 5 extracts increased, rather than decreased, anxiety levels.(Elsas 2010) Anticonvulsant activity in mice has been reported in other studies.(Nassiri-Asl 2007, Singh 2012)

In one study, passionflower extract was shown to positively modulate circadian rhythms in NIH3T3 cells and in mice.(Toda 2017)

One study using in vitro and in vivo models suggested antidepressive therapeutic effects with a combination extract of Hypericum perforatum and P. incarnata.(Fiebich 2011)

Clinical data

A published Cochrane review evaluating the efficacy of Passiflora in anxiety included trials through 2005; the authors concluded that too few quality clinical trials of Passiflora exist to provide a definitive recommendation regarding a place in therapy. Two studies were included in the review, with one of the studies suggesting equivalence with benzodiazepines. Dosages used in the 2 trials were 45 drops/day of a P. incarnata extract, or a 90 mg/day tablet.(Miyasaka 2007) In a small clinical trial, P. incarnata extract 500 mg was effective as a preoperative anxiolytic, with reductions in numerical rating scale anxiety scores compared to placebo (P<0.001).(Movafegh 2008) In a small crossover study in adults undergoing dental surgery (N=40), P. incarnata 260 mg (1 pill) orally 30 minutes prior to surgery demonstrated a preoperative anxiolytic effect similar to midazolam. The study evaluated effects on blood pressure, heart rate, and oxygen saturation (as physical parameters associated with anxiety level), with no differences, except in diastolic blood pressure, observed. However, data reflected a much higher proportion of anxious feelings during the second extraction in patients who received P. incarnata during the first extraction compared to those who received midazolam during the first extraction. P. incarnata administration was not associated with memory interference, while midazolam was associated with amnesia.(Dantas 2017) Results reported by a larger randomized, triple-blind, controlled study (N=200) support this effect. P. incarnata capsules (500 mg) or midazolam (15 mg) administered orally 1 hour before surgery resulted in lower levels of anxiety during dental surgery than placebo, with no significant difference seen between the 2 treatment groups.(da Cunha 2021) Similarly, patients undergoing periodontal treatment experienced a reduction in anxiety levels with passion flower extract given as 20 drops the night before and 20 drops the morning of the procedure. (Kaviani 2013) Despite widespread acceptance as a natural anxiolytic, other reviews similarly report on the lack of clinical evidence for P. incarnata in anxiety-related disorders.(Lakhan 2010, Sarris 2013, Sarris 2011) One small, randomized, placebo-controlled, crossover pilot study in adults with mild fluctuations in sleep quality evaluated the effects of P. incarnata administered as a tea (tea bags containing 2 g of dried P. incarnata leaves, stems, seeds, and flowers) at bedtime for 7 days. Patient-rated sleep quality was improved with active treatment compared with placebo tea bags, but no other measures (ie, total sleep time, sleep efficiency, feeling of refreshment) were different. No difference between groups in anxiety scores at the end of the 7-night treatment period was reported. A 1-week washout between treatments was used in the study.(Ngan 2011) Another study found the product Passiflora Compose to improve anxiety and sleep disorders.(Villet 2016)

In a prospective, randomized, double-blind, placebo-controlled study, 60 patients scheduled for spinal anesthesia were randomized to receive an oral aqueous extract of P. incarnata 700 mg per 5 mL or placebo 30 minutes before anesthesia. A statistically significant increase in anxiety scores was noted from baseline to just prior to spinal anesthesia in those receiving placebo compared to P. incarnata. The authors suggest that preoperative administration of P. incarnata suppresses the increase in anxiety associated with spinal anesthesia.(Aslanargun 2012) Similar findings were demonstrated in another study, in which P. incarnata 1,000 mg was given an hour before elective surgery; P. incarnata was associated with reductions in anxiety comparable to reductions in patients receiving melatonin. However, P. incarnata was associated with more cognitive impairment than melatonin.(Rokhtabnak 2016)

In a multicenter, prospective observational study of children 6 to 12 years of age with a history of nervousness and agitation due to affective disorders, treatment with a combination of P. incarnata, Hypericum perforatum, and Valeriana officinalis improved symptoms of nervous agitation such as depression, school/examination anxieties, other anxieties, sleeping problems, and various physical problems.(Trompetter 2013)

In a study of patients experiencing opiate withdrawal, a combination of P. incarnata and clonidine was superior to clonidine alone in improving mental symptom scores.(Akhondzadeh 2001)

Twelve weeks of treatment with a dried ethanolic extract improved resilience and quality of life in patients with "nervous restlessness."(Gibbert 2017)


Animal and in vitro data

In studies evaluating effects of P. edulis in rodents, increased high-density lipoprotein and decreased low-density lipoprotein and free fatty acids have been achieved, possibly due to pectin content of the supplementation.(de Souza Mda 2012, Silva 2011) Reductions in fasting blood glucose levels have been achieved in mice with induced diabetes.(Barbalho 2011, Gupta 2012) Reductions noted may be due to changes in absorption secondary to inhibition of alpha-glycoside activity.(Sudasinghe 2018)

Clinical data

In a small clinical trial of patients with type 2 diabetes, passion fruit peel flour (from P. edulis), which is rich in soluble fiber and pectin, was used as a supplement and led to improvements in fasting blood glucose and glycosylated hemoglobin levels.(de Queiroz Mdo 2012) In a systematic review and meta-analysis that purported a comparison between passion fruit peel flour and turmeric, 2 of the 4 passiflora studies combined in the analyses were of leaf extract and not fruit peel flour. From this mixed data, the authors claimed a weak effect of passion fruit peel flour on glycemic control.(Sousa 2019)

Diverticular disease

In vitro data

Results of a study show yellow passion fruit rind is a potential dietary fiber source, and may help protect against diverticular diseases.(Yapo 2008)

Menopausal symptoms

Clinical data

In a study of menopausal women, passion flower significantly reduced menopausal symptoms (ie, vasomotor symptoms, insomnia, depression, anger, headache, muscular/joint pain, numbness) in the third and sixth weeks of the study (P<0.05).(Fahami 2010)


Published clinical data are lacking to support therapeutic dosing guidance.

Traditional doses for use as a mild sedative have included 0.5 to 2 g of P. incarnata aerial plant parts taken 3 to 4 times daily; 2.5 g of aerial parts as an infusion 3 to 4 times daily; or 1 to 4 mL of a tincture (1:8) 3 to 4 times daily.WHO 2007

Various doseforms and dosages have been used in small clinical trials evaluating P. incarnata as a preoperative anxiolytic. In a Cochrane review, dosages used in clinical trials evaluating Passiflora for anxiety disorder included 45 drops/day of an extract, or a 90 mg/day tablet.Miyasaka 2007

A small pilot study in adults used a tea solution (prepared by steeping bags containing 2 g of dried P. incarnata for 10 minutes in boiling water) administered over 7 days to evaluate effects on sleep quality.Ngan 2011

Pregnancy / Lactation

Use of passion flower is contraindicated during pregnancy because of uterine stimulant action of its alkaloids harman and harmaline, as demonstrated in animal models and in vitro studies, and the content of the cyanogenic glycoside gynocardin.Ernst 2002, WHO 2007 Information regarding use of passionflower during lactation is lacking.


Caution is warranted with coadministration of CNS-active medicines(Dhawan 2004, Modabbernia 2013); an additive effect with St. John's wort has been suggested.(Fiebich 2011)

Case reports are lacking regarding interactions with warfarin and other anticoagulants; however, compounds identified from P. edulis extracts have exhibited anticoagulant activity in vitro.(Sato 2012) Therefore, there is theoretically an increased risk for prolonged bleeding with coadministration of P. incarnata and anticoagulants.

Caution is warranted with coadministration of drugs that prolong the QT interval.(Dhawan 2004, Miyasaka 2007, WHO 2007)

Benzodiazepines: Passion flower may enhance the adverse/toxic effect of benzodiazepines. Monitor therapy.(Akhondzadeh 2001, Appel 2011, Carrasco 2009, Khom 2007)

Adverse Reactions

Nausea, vomiting, dizziness, confusion, ataxia, and drowsiness have been reported with passionflower consumption, as well as prolongation of the QT interval and episodes of ventricular tachycardia. Hypersensitivity, occupational asthma, and rhinitis have also been reported.Baek 2014, Dhawan 2004, Fisher 2000, Miyasaka 2007, Rodriguez-Fragoso 2008, WHO 2007, Wohlmuth 2010


Information is limited and cannot be extrapolated from one species to another. P. incarnata has GRAS status according to the FDA.FDA 2018 Some Passiflora species reportedly exhibit genotoxicity.Boeira 2010, Mills 2006, Tabach 2009, WHO 2007 The constituents harman and harmine are considered mutagenic and genotoxic.Mills 2006 Several species of Passiflora have cyanogenic constituents, while others are associated with toxicological reports of immunoglobulin E–mediated allergy, vasculitis, altered consciousness, hepatobiliary, and pancreatic toxicity.Braga 2013, Devaki 2012, Dhawan 2004 A report of disruption of sexual behavior in adult male rat progeny has been published, and is possibly due to aromatase inhibition by P. incarnata.Bacchi 2013

Index Terms



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

More about passion flower

Related treatment guides

Akhondzadeh S, Kashani L, Moaseri M, Hosseini SH, Nikzad S, Khani M. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J Clin Pharm Ther. 2001;26(5):369-373.11679027
Akhondzadeh S, Naghavi HR, Vazirian M, Sayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363-367.11679026
Aman U, Subhan F, Shahid M, et al. Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms. BMC Complement Altern Med. 2016;16:77.26912265
Appel K, Rose T, Fiebich B, Kammler T, Hoffmann C, Weiss G. Modulation of the gamma-aminobutyric acid (GABA) system by Passiflora incarnata L. Phytother Res. 2011;25(6):838-843.21089181
Aslanargun P, Cuvas O, Dikmen B, Aslan E, Yuksel MU. Passiflora incarnata Linneaus as an anxiolytic before spinal anesthesia. J Anesth. 2012;26(1):39-44.22048283
Bacchi AD, Ponte B, Vieira ML, et al. Developmental exposure to Passiflora incarnata induces behavioural alterations in the male progeny. Reprod Fertil Dev. 2013;25(5):782-789.22958428
Baek JH, Nierenberg AA, Kinrys G. Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder. Aust N Z J Psychiatry. 2014;48(8):705-715.24947278
Barbalho SM, Damasceno DC, Spada AP, et al. Effects of Passiflora edulis on the metabolic profile of diabetic Wistar rat offspring. J Med Food. 2011;14(12):1490-1495.21663518
Boeira JM, Fenner R, Betti AH, et al. Toxicity and genotoxicity evaluation of Passiflora alata Curtis (Passifloraceae). J Ethnopharmacol. 2010;128(2):526-532.19799991
Braga A, Stein AC, Dischkaln Stolz E, et al. Repeated administration of an aqueous spray-dried extract of the leaves of Passiflora alata Curtis (Passifloraceae) inhibits body weight gain without altering mice behavior. J Ethnopharmacol. 2013;145(1):59-66.23107823
Breivogel C, Jamerson B. Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats. Pharm Biol. 2012;50(10):1310-1316.22873194
Carrasco MC, Vallejo JR, Pardo-de-Santayana M, Peral D, Martin MA, Altimiras J. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother Res. 2009;23(12):1795-1796.19441067
Code of Federal Regulation Title 21. US Food and Drug Administration Web site. Accessed February 18, 2018.
da Cunha RS, Amorim KS, Gercina AC, et al. Herbal medicines as anxiolytics prior to third molar surgical extraction. A randomized controlled clinical trial. Clin Oral Investig. 2021;25(3):1579-1586.32951121
Dantas LP, de Oliveira-Ribeiro A, de Almeida-Souza LM, Groppo FC. Effects of Passiflora incarnata and midazolam for control of anxiety in patients undergoing dental extraction. Med Oral Patol Oral Cir Bucal. 2017;22(1):e95-e101.27918731
Deng J, Zhou Y, Bai M, Li H, Li L. Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa. J Ethnopharmacol. 2010;128(1):148-153.20051259
de Queiroz Mdo S, Janebro DI, da Cunha MA, et al. Effect of the yellow passion fruit peel flour (Passiflora edulis f. flavicarpa deg.) in insulin sensitivity in type 2 diabetes mellitus patients. Nutr J. 2012;11:89.23088514
de Souza Mda S, Barbalho SM, Damasceno DC, et al. Effects of Passiflora edulis (yellow passion) on serum lipids and oxidative stress status of Wistar rats. J Med Food. 2012;15(1):78-82.21877954
Devaki K, Beulah U, Akila G, Gopalakrishnan VK. Effect of aqueous extract of Passiflora edulis on biochemical and hematological parameters of wistar albino rats. Toxicol Int. 2012;19(1):63-67.22736906
Devi Ramaiya S, Bujang JS, Zakaria MH, King WS, Shaffiq Sahrir MA. Sugars, ascorbic acid, total phenolic content and total antioxidant activity in passion fruit (Passiflora) cultivars. J Sci Food Agric. 2013;93(5):1198-1205.23027609
Dhawan K, Dhawan S, Sharma, A. Passiflora: a review update. J Ethnopharmacol. 2004;94(1):1-23.15261959
Dhawan K, Kumar S, Sharma A. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia. 2001;72(8):922-926.11731118
Dhawan K, Kumar S, Sharma A. Comparative biological activity study on Passiflora incarnata and P. edulis. Fitoterapia. 2001;72(6):698-702.11543974
Dhawan K, Sharma A. Antitussive activity of the methanol extract of Passiflora incarnata leaves. Fitoterapia. 2002;73(5):397-399.12165335
Elsas SM, Rossi DJ, Raber J, et al. Passiflora incarnata L. (passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010;17(12):940-949.20382514
Ernst E. Herbal medicinal products during pregnancy: are they safe? BJOG. 2002;109(3):227-235.11950176
Fahami F, Asali Z, Aslani A, Fathizadeh N. A comparative study on the effects of Hypericum perforatum and passion flower on the menopausal symptoms of women referring to Isfahan city health care centers. Iran J Nurs Midwifery Res. 2010;15(4):202-207.22049281
Farid R, Rezaieyazdi Z, Mirfeizi Z, et al. Oral intake of purple passion fruit peel extract reduces pain and stiffness and improves physical function in adult patients with knee osteoarthritis. Nutr Res. 2010;30(9):601-606.20934601
Fiebich BL, Knorle R, Appel K, Kammler T, Weiss G. Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): in vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models. Fitoterapia. 2011;82(3):474-480.21185920
Fisher AA, Purcell P, Le Couteur DG. Toxicity of Passiflora incarnata L. J ToxicolClin Toxicol. 2000;38(1):63-66.10696928
Gibbert J, Kreimendahl F, Lebert J, Rychlik R, Trompetter I. Improvement of stress resistance and quality of life of adults with nervous restlessness after treatment with a passion flower dry extract [article in German]. Complement Med Res. 2017;24(2):83-89.28407638
Gupta RK, Kumar D, Chaudhary AK, Maithani M, Singh R. Antidiabetic activity of Passiflora incarnata Linn. in streptozotocin-induced diabetes in mice. J Ethnopharmacol. 2012;139(3):801-806.22212504
Hamid HA, Ramli AN, Yusoff MM. Indole alkaloids from plants as potential leads for antidepressant drugs: A mini review. Front Pharmacol. 2017;8:96.28293192
Herba passiflorae. In: WHO Monographs on Selected Medicinal Plants. Vol. 3. Geneva, Switzerland: World Health Organization; 2007.
Ingale SP, Kasture SB. Protective effect of standardized extract of Passiflora incarnata flower in Parkinson's and Alzheimer's disease. Anc Sci Life.2017;36(4):200-206.29269972
Jawna-Zboińska K, Blecharz-Klin K, Joniec-Maciejak I, et al. Passiflora incarnata L. improves spatial memory, reduces stress, and affects neurotransmission in rats. Phytother Res.2016;30(5):781-789.26814055
Kaviani N, Tavakoli M, Tabanmehr MR, Havaei RA. The efficacy of Passiflora incarnata Linnaeus in reducing dental anxiety in patients undergoing periodontal treatment. J Dent (Shiraz). 2013;14(2):68-72.24724122
Khan IA, Abourashed EA. Leung's Encyclopedia of Common Natural Ingredients: Used in Food, Drugs, and Cosmetics. 3rd ed. Hoboken, NJ: Wiley; 2009.
Khom S, Baburin I, Timin E, et al. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology. 2007;53(1):178-187.17585957
Konta EM, Almeida MR, Amaral CL, et al. Evaluation of the antihypertensive properties of yellow passion fruit pulp (Passiflora edulis Sims f. flavicarpa Deg.) in spontaneously hypertensive rats. Phytother Res. 2014;28(1):28-32.23436457
Lakhan SE, Vieira KF. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Nutr J. 2010;9:42.20929532
Lam SK, Ng TB. Passiflin, a novel dimeric antifungal protein from seeds of the passion fruit. Phytomedicine. 2009;16(2-3):172-180.19200704
Lewis BJ, Herrlinger KA, Craig TA, Mehring-Franklin CE, Defreitas Z, Hinojosa-Laborde C. Antihypertensive effect of passion fruit peel extract and its major bioactive components following acute supplementation in spontaneously hypertensive rats. J Nutr Biochem. 2013;24(7):1359-1366.23333089
Lourith N, Kanlayavattanakul M. Antioxidant activities and phenolics of Passiflora edulis seed recovered from juice production residue. J Oleo Sci. 2013;62(4):235-240.23535311
Masadeh MM, Alkofahi AS, Alzoubi KH, Tumah HN, Bani-Hani K. Anti-Helicobacter pylori activity of some Jordanian medicinal plants. Pharm Biol. 2014;52(5):566-569.24251817
Masteikova R, Bernatoniene J, Bernatoniene R, Velziene S. Antiradical activities of the extract of Passiflora incarnata. Acta Pol Pharm. 2008;65(5):577-583.19051605
Mills E, Dugoua JJ, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation: An Evidence-Based Approach. United Kingdom: Taylor & Francis Medical; 2006.
Miyasaka LS, Atallah AN, Soares BG. Passiflora for anxiety disorder. Cochrane Database Syst Rev. 2007;(1):CD004518.17253512
Modabbernia A, Akhondzadeh S. Saffron, passionflower, valerian and sage for mental health. Psychiatr Clin North Am. 2013;36(1):85-91.23538079
Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg. 2008;106(6):1728-1732.18499602
Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med. 2007;7:26.17686156
Ngan A, Conduit R. A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytother Res. 2011;25(8):1153-1159.21294203
Passiflora incarnata L. USDA, NRCS. 2018. The PLANTS Database. ( 2018). National Plant Data Team, Greensboro, NC 27401-4901 USA. Accessed February 12, 2018.
Rocha TD, de Brum Vieira P, Gnoatto SC, Tasca T, Gosmann G. Anti-Trichomonas vaginalis activity of saponins from Quillaja, Passiflora, and Ilex species. Parasitol Res. 2012;110(6):2551-2556.22218924
Rodriguez-Fragoso L, Reyes-Esparza J, Burchiel SW, Herrera-Ruiz D, Torres E. Risks and benefits of commonly used herbal medicines in Mexico. Toxicol Appl Pharmacol. 2008;227(1):125-135.18037151
Rokhtabnak F, Ghodraty MR, Kholdebarin A, et al. Comparing the effect of preoperative administration of melatonin and Passiflora incarnata on postoperative cognitive disorders in adult patients undergoing elective surgery. Anesth Pain Med. 2016;7(1):e41238.28920038
Sampath C, Holbik M, Krenn L, Butterweck V. Anxiolytic effects of fractions obtained from Passiflora incarnata L. in the elevated plus maze in mice. Phytother Res. 2011;25(6):789-795.21077264
Sano S, Sugiyama K, Ito T, Katano Y, Ishihata A. Identification of the strong vasorelaxing substance scirpusin B, a dimer of piceatannol, from passion fruit (Passiflora edulis) seeds. J Agric Food Chem. 2011;59(11):6209-6213.21526844
Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence [published correction appears in CNS Drugs. 2013;27(8):675]. CNS Drugs. 2013;27(4):301-319.23653088
Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21(12):841-860.21601431
Sasikala V, Saravanan S, Parimelazhagan T. Analgesic and anti-inflammatory activities of Passiflora foetida L. Asian Pac J Trop Med. 2011;4(8):600-603.21914535
Sathish R, Sahu A, Natarajan K. Antiulcer and antioxidant activity of ethanolic extract of Passiflora foetida L. Indian J Pharmacol. 2011;43(3):336-339.21713043
Sato AC, Andrade SA, Brito MV, et al. Effects of compounds from Passiflora edulis Sims f. flavicarpa juice on blood coagulation and on proteolytic enzymes. Protein Pept Lett. 2012;19(5):501-508.22486645
Schunck RV, Macedo IC, Laste G, et al. Standardized Passiflora incarnata L. extract reverts the analgesia induced by alcohol withdrawal in rats. Phytother Res. 2017;31(8):1199-1208.28568647
Silva DC, Freitas AL, Pessoa CD, et al. Pectin from Passiflora edulis shows anti-inflammatory action as well as hypoglycemic and hypotriglyceridemic properties in diabetic rats. J Med Food. 2011;14(10):1118-1126.21554121
Singh B, Singh D, Goel RK. Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression. J Ethnopharmacol. 2012;139(1):273-279.22107833
Sousa DF, Veras VS, Freire VE, et al. Effectiveness of passion fruit peel flour (Passiflora edulis L.) versus turmeric flour (Curcuma longa L.) on glycemic control: systematic review and meta-analysis. Curr Diabetes Rev. 2019 Oct 26. [epub ahead of print]31738145
Sudasinghe HP, Peiris DC. Hypoglycemic and hypolipidemic activity of aqueous leaf extract of Passiflora suberosa L. PeerJ. 2018;6: e4389.29479498
Tabach R, Rodrigues E, Carlini EA. Preclinical toxicological assessment of a phytotherapeutic product–CPV (based on dry extracts of Crataegus oxyacantha L., Passiflora incarnata L., and Valeriana officinalis L.). Phytother Res. 2009;23(1):33-40.19048610
Toda K, Hitoe S, Takeda S, Shimizu N, Shimoda H. Passionflower extract induces high-amplitude rhythms without phase shifts in the expression of several circadian clock genes in vitro and in vivo. Int J Biomed Sci. 2017;13(2):84-92.28824345
Tomczyk M, Zocko-Koncić M, Chrostek L. Phytotherapy of alcoholism. Nat Prod Commun. 2012;7(2):273-280.22474979
Trompetter I, Krick B, Weiss G. Herbal triplet in treatment of nervous agitation in children. Wien Med Wochenshr. 2013;163(3-4):52-57.23179673
Villet S, Vacher V, Colas A, et al. Open-label observational study of the homeopathic medicine Passiflora compose for anxiety and sleep disorders. Homeopathy. 2016;105(1):84-91.26828002
Watson RR, Zibadi S, Rafatpanah H, et al. Oral administration of the purple passion fruit peel extract reduces wheeze and cough and improves shortness of breath in adults with asthma. Nutr Res. 2008;28(3):166-171.19083404
Wohlmuth H, Penman KG, Pearson T, Lehmann RP. Pharmacognosy and chemotypes of passionflower (Passiflora incarnata L.). Biol Pharm Bull. 2010;33(6):1015-1018.20522969
Yapo BM, Koffi KL. Dietary fiber components in yellow passion fruit rind–a potential fiber source. J Agric Food Chem. 2008;56(14):5880-5883.18558700

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.